PatientsLikeMe : Scopolamine Transdermal Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.

Patients

Taking Scopolamine Transdermal
8 Patients currently take Scopolamine Transdermal
6 Patients stopped taking Scopolamine Transdermal
egbokmom Sensation: Moderate Overall: Mild Cognition: moderate Vision: moderate Speech: none Swallowing: none Upper limb: moderate Walking: severe See profile egbokmom 1.5mg daily since Mar 13, 2008
gurichri Mouth/throat: severe Arms: severe Chest: moderate Legs: severe See profile gurichri mg daily since Oct 09, 2007

Brand Names: Transderm Scop
See also: Scopolamine

What is Scopolamine Transdermal? Scopolamine, also known as hyoscine, is a tropane alkaloid drug obtained from plants of the family Solanaceae (nightshades), such as henbane or jimson weed (Datura species). It is used to reduce excessive saliva and oral secretions. Read more...

See more information, including instructions, precautions, side effects, and interactions.

Jump to:: Reasons Taken; Dosages; Duration; Patient Evaluations

Reasons Taken

14 patients in the community are taking or have taken Scopolamine Transdermal.

Reason	# Patients	Percentage of patients
Excess saliva	9	64%
Vertigo	1	7%
Other	1	7%
disease-related symptoms	1	7%

Dosages

Based on the patients currently taking Scopolamine Transdermal.

0 mg day	0.5 mg day	1.5 mg day	5 g day
5	1	1	1

Duration

How long current patients have been taking Scopolamine Transdermal or how long patients were taking Scopolamine Transdermal before stopping.

Currently taking Scopolamine Transdermal

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
0	0	0	1	2	0

Stopped taking Scopolamine Transdermal

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
3	0	1	2	0	0

Why Patients Stopped Taking Scopolamine Transdermal (multiple reasons could be selected)
Reason	# Patients	Percentage of patients
Did not seem to work	3	50%
Side effects too severe	2	33%
Expense	1	17%
Other	1	17%
Not indicated	1	17%

Patient Reported Evaluations

Results from 2 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

None	100%	1

Vertigo

Side-effects (as an overall problem)

Severe	50%	1
Moderate	0%	0
Mild	0%	0
None	50%	1

Top reported side-effects include: skin irritation

Summary results are based on 2 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (2 of 2)

Boo Boo

Mouth/throat: mild

Arms: none

Chest: none

Legs: none

See profile
by Boo Boo
Apr 01, 2008

EfficacyModerate
Side-effectsSevere

Other

See full evaluation
0 helpful marks

Dymond

Sensation: Moderate

Overall: None

Cognition: none

Vision: mild

Speech: none

Swallowing: none

Upper limb: none

Walking: none

See profile
by Dymond
Jun 16, 2008